Mindbloom
Provides guided at-home ketamine therapy for mental health.
biotechmental-healthpharmaceuticalstelehealth
Company facts
- Founded
- 2018
- Employees
- 230
- Headquarters
- United States
- CEO
- Dylan Beynon
- Type
- Private
- Funding
- Series A · $44.9M · 2021
About
Mindbloom delivers guided at-home ketamine therapy to improve mental health, combining psychedelic medicine with structured integration support. The company partners with medical leaders to run a best-in-class treatment program that has produced measurable, transformational outcomes for patients. Mindbloom's remote-first, award-winning culture and backing from Tier 1 venture capital enable rapid scaling while maintaining high standards of care. Its mission is to transform lives and, ultimately, the mental-health landscape through innovative, evidence-based psychedelic therapy.
6 jobs